Compounds > eriodictyol
Page last updated: 2024-08-21

eriodictyol and isosakuranetin

eriodictyol has been researched along with isosakuranetin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Baird, WM; Cassady, JM; Cook, VM; Ho, DK; Liu, YL1
Habtemariam, S1
Itoh, T; Sakakibara, H; Shimoi, K; Takemura, H; Yamamoto, K1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Barreca, D; Bellocco, E; Calderaro, A; Daglia, M; Gattuso, G; Laganà, G; Meneghini, S; Nabavi, SM; Smeriglio, A; Trombetta, D1
Erdoğan, Ş; Özbakır Işın, D1

Reviews

1 review(s) available for eriodictyol and isosakuranetin

ArticleYear
Flavanones: Citrus phytochemical with health-promoting properties.
    BioFactors (Oxford, England), 2017, Jul-08, Volume: 43, Issue:4

    Topics: Animals; Antioxidants; Citrus; Flavanones; Flavonoids; Hesperidin; Humans; Oxidative Stress

2017

Other Studies

5 other study(ies) available for eriodictyol and isosakuranetin

ArticleYear
Isolation of potential cancer chemopreventive agents from Eriodictyon californicum.
    Journal of natural products, 1992, Volume: 55, Issue:3

    Topics: Animals; Anticarcinogenic Agents; Benzo(a)pyrene; Cells, Cultured; Cricetinae; Depression, Chemical; DNA, Neoplasm; Female; Flavonoids; Plants, Medicinal; Pregnancy

1992
Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells.
    Journal of natural products, 1997, Volume: 60, Issue:8

    Topics: Animals; Apoptosis; Drug Synergism; Flavonoids; Mice; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1997
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
    Bioorganic & medicinal chemistry, 2010, Sep-01, Volume: 18, Issue:17

    Topics: Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Flavonoids; Humans; Models, Molecular; Structure-Activity Relationship

2010
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
A DFT study on OH radical scavenging activities of eriodictyol, Isosakuranetin and pinocembrin.
    Journal of biomolecular structure & dynamics, 2022, Volume: 40, Issue:21

    Topics: Antioxidants; Flavonoids; Free Radical Scavengers; Humans; Hydrogen; Protons; Thermodynamics

2022